Disease | dystonia |
Phenotype | C0018523|pantothenate kinase-associated neurodegeneration |
Sentences | 1 |
PubMedID- 23277004 | This has encouraged the application of dbs technology to treat a number of other neurodegenerative conditions, including secondary dystonia associated with pantothenate kinase-associated neurodegeneration (pkan, formerly hallervorden-spatz syndrome), chorea associated with huntington's disease, and most recently, cognitive decline associated with alzheimer's type dementia. |
Page: 1